The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma.
Identifieur interne : 001727 ( Main/Exploration ); précédent : 001726; suivant : 001728The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma.
Auteurs : Jessica Berger [États-Unis] ; Eirwen Scott ; Paniti Sukumvanich ; Ashlee Smith ; Alexander Olawaiye ; John Comerci ; Joseph L. Kelley ; Sushil Beriwal ; Marilyn HuangSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aine (anatomopathologie), Association thérapeutique (effets indésirables), Carcinome épidermoïde (), Carcinome épidermoïde (anatomopathologie), Femelle, Grading des tumeurs, Humains, Lymphoedème (anatomopathologie), Lymphoedème (étiologie), Maladie chronique, Noeuds lymphatiques (anatomopathologie), Pronostic, Protocoles de polychimiothérapie antinéoplasique (effets indésirables), Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs de la vulve (), Tumeurs de la vulve (anatomopathologie), Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Aine, Carcinome épidermoïde, Lymphoedème, Noeuds lymphatiques, Tumeurs de la vulve.
- effets indésirables : Association thérapeutique, Protocoles de polychimiothérapie antinéoplasique.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Carcinome épidermoïde, Femelle, Grading des tumeurs, Humains, Maladie chronique, Pronostic, Stade de la tumeur, Sujet âgé, Sujet âgé de 80 ans ou plus, Tumeurs de la vulve, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols (adverse effects), Carcinoma, Squamous Cell (complications), Carcinoma, Squamous Cell (pathology), Carcinoma, Squamous Cell (therapy), Chronic Disease, Combined Modality Therapy (adverse effects), Female, Follow-Up Studies, Groin (pathology), Humans, Lymph Nodes (pathology), Lymphedema (etiology), Lymphedema (pathology), Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Retrospective Studies, Vulvar Neoplasms (complications), Vulvar Neoplasms (pathology), Vulvar Neoplasms (therapy).
- MESH :
- adverse effects : Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy.
- complications : Carcinoma, Squamous Cell, Vulvar Neoplasms.
- etiology : Lymphedema.
- pathology : Carcinoma, Squamous Cell, Groin, Lymph Nodes, Lymphedema, Vulvar Neoplasms.
- therapy : Carcinoma, Squamous Cell, Vulvar Neoplasms.
- Adult, Aged, Aged, 80 and over, Chronic Disease, Female, Follow-Up Studies, Humans, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Retrospective Studies.
Abstract
Chronic lymphedema (CL) after inguinal lymph node dissection (ILND) or radiotherapy (RT) is a significant problem for vulvar cancer survivors. The treatment modality or combination of therapies that poses the greatest risk is not known. The objective of this study was to describe rates of clinically significant CL conferred by different groin treatment modalities.
DOI: 10.1097/IGC.0000000000000311
PubMed: 25415076
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001194
- to stream PubMed, to step Curation: 001194
- to stream PubMed, to step Checkpoint: 001194
- to stream Ncbi, to step Merge: 006D48
- to stream Ncbi, to step Curation: 006D48
- to stream Ncbi, to step Checkpoint: 006D48
- to stream Main, to step Merge: 001729
- to stream Main, to step Curation: 001727
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma.</title><author><name sortKey="Berger, Jessica" sort="Berger, Jessica" uniqKey="Berger J" first="Jessica" last="Berger">Jessica Berger</name><affiliation wicri:level="2"><nlm:affiliation>*Division of Gynecologic Oncology, †Department of Obstetrics, Gynecology, and Reproductive Sciences, and ‡Department of Radiation Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>*Division of Gynecologic Oncology, †Department of Obstetrics, Gynecology, and Reproductive Sciences, and ‡Department of Radiation Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Scott, Eirwen" sort="Scott, Eirwen" uniqKey="Scott E" first="Eirwen" last="Scott">Eirwen Scott</name></author><author><name sortKey="Sukumvanich, Paniti" sort="Sukumvanich, Paniti" uniqKey="Sukumvanich P" first="Paniti" last="Sukumvanich">Paniti Sukumvanich</name></author><author><name sortKey="Smith, Ashlee" sort="Smith, Ashlee" uniqKey="Smith A" first="Ashlee" last="Smith">Ashlee Smith</name></author><author><name sortKey="Olawaiye, Alexander" sort="Olawaiye, Alexander" uniqKey="Olawaiye A" first="Alexander" last="Olawaiye">Alexander Olawaiye</name></author><author><name sortKey="Comerci, John" sort="Comerci, John" uniqKey="Comerci J" first="John" last="Comerci">John Comerci</name></author><author><name sortKey="Kelley, Joseph L" sort="Kelley, Joseph L" uniqKey="Kelley J" first="Joseph L" last="Kelley">Joseph L. Kelley</name></author><author><name sortKey="Beriwal, Sushil" sort="Beriwal, Sushil" uniqKey="Beriwal S" first="Sushil" last="Beriwal">Sushil Beriwal</name></author><author><name sortKey="Huang, Marilyn" sort="Huang, Marilyn" uniqKey="Huang M" first="Marilyn" last="Huang">Marilyn Huang</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25415076</idno><idno type="pmid">25415076</idno><idno type="doi">10.1097/IGC.0000000000000311</idno><idno type="wicri:Area/PubMed/Corpus">001194</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001194</idno><idno type="wicri:Area/PubMed/Curation">001194</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001194</idno><idno type="wicri:Area/PubMed/Checkpoint">001194</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001194</idno><idno type="wicri:Area/Ncbi/Merge">006D48</idno><idno type="wicri:Area/Ncbi/Curation">006D48</idno><idno type="wicri:Area/Ncbi/Checkpoint">006D48</idno><idno type="wicri:Area/Main/Merge">001729</idno><idno type="wicri:Area/Main/Curation">001727</idno><idno type="wicri:Area/Main/Exploration">001727</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma.</title><author><name sortKey="Berger, Jessica" sort="Berger, Jessica" uniqKey="Berger J" first="Jessica" last="Berger">Jessica Berger</name><affiliation wicri:level="2"><nlm:affiliation>*Division of Gynecologic Oncology, †Department of Obstetrics, Gynecology, and Reproductive Sciences, and ‡Department of Radiation Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>*Division of Gynecologic Oncology, †Department of Obstetrics, Gynecology, and Reproductive Sciences, and ‡Department of Radiation Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh</wicri:cityArea></affiliation></author><author><name sortKey="Scott, Eirwen" sort="Scott, Eirwen" uniqKey="Scott E" first="Eirwen" last="Scott">Eirwen Scott</name></author><author><name sortKey="Sukumvanich, Paniti" sort="Sukumvanich, Paniti" uniqKey="Sukumvanich P" first="Paniti" last="Sukumvanich">Paniti Sukumvanich</name></author><author><name sortKey="Smith, Ashlee" sort="Smith, Ashlee" uniqKey="Smith A" first="Ashlee" last="Smith">Ashlee Smith</name></author><author><name sortKey="Olawaiye, Alexander" sort="Olawaiye, Alexander" uniqKey="Olawaiye A" first="Alexander" last="Olawaiye">Alexander Olawaiye</name></author><author><name sortKey="Comerci, John" sort="Comerci, John" uniqKey="Comerci J" first="John" last="Comerci">John Comerci</name></author><author><name sortKey="Kelley, Joseph L" sort="Kelley, Joseph L" uniqKey="Kelley J" first="Joseph L" last="Kelley">Joseph L. Kelley</name></author><author><name sortKey="Beriwal, Sushil" sort="Beriwal, Sushil" uniqKey="Beriwal S" first="Sushil" last="Beriwal">Sushil Beriwal</name></author><author><name sortKey="Huang, Marilyn" sort="Huang, Marilyn" uniqKey="Huang M" first="Marilyn" last="Huang">Marilyn Huang</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Antineoplastic Combined Chemotherapy Protocols (adverse effects)</term><term>Carcinoma, Squamous Cell (complications)</term><term>Carcinoma, Squamous Cell (pathology)</term><term>Carcinoma, Squamous Cell (therapy)</term><term>Chronic Disease</term><term>Combined Modality Therapy (adverse effects)</term><term>Female</term><term>Follow-Up Studies</term><term>Groin (pathology)</term><term>Humans</term><term>Lymph Nodes (pathology)</term><term>Lymphedema (etiology)</term><term>Lymphedema (pathology)</term><term>Middle Aged</term><term>Neoplasm Grading</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Retrospective Studies</term><term>Vulvar Neoplasms (complications)</term><term>Vulvar Neoplasms (pathology)</term><term>Vulvar Neoplasms (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aine (anatomopathologie)</term><term>Association thérapeutique (effets indésirables)</term><term>Carcinome épidermoïde ()</term><term>Carcinome épidermoïde (anatomopathologie)</term><term>Femelle</term><term>Grading des tumeurs</term><term>Humains</term><term>Lymphoedème (anatomopathologie)</term><term>Lymphoedème (étiologie)</term><term>Maladie chronique</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Pronostic</term><term>Protocoles de polychimiothérapie antinéoplasique (effets indésirables)</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs de la vulve ()</term><term>Tumeurs de la vulve (anatomopathologie)</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term><term>Combined Modality Therapy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Aine</term><term>Carcinome épidermoïde</term><term>Lymphoedème</term><term>Noeuds lymphatiques</term><term>Tumeurs de la vulve</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Association thérapeutique</term><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Groin</term><term>Lymph Nodes</term><term>Lymphedema</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Carcinoma, Squamous Cell</term><term>Vulvar Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Chronic Disease</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Middle Aged</term><term>Neoplasm Grading</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Carcinome épidermoïde</term><term>Femelle</term><term>Grading des tumeurs</term><term>Humains</term><term>Maladie chronique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs de la vulve</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Chronic lymphedema (CL) after inguinal lymph node dissection (ILND) or radiotherapy (RT) is a significant problem for vulvar cancer survivors. The treatment modality or combination of therapies that poses the greatest risk is not known. The objective of this study was to describe rates of clinically significant CL conferred by different groin treatment modalities.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><noCountry><name sortKey="Beriwal, Sushil" sort="Beriwal, Sushil" uniqKey="Beriwal S" first="Sushil" last="Beriwal">Sushil Beriwal</name><name sortKey="Comerci, John" sort="Comerci, John" uniqKey="Comerci J" first="John" last="Comerci">John Comerci</name><name sortKey="Huang, Marilyn" sort="Huang, Marilyn" uniqKey="Huang M" first="Marilyn" last="Huang">Marilyn Huang</name><name sortKey="Kelley, Joseph L" sort="Kelley, Joseph L" uniqKey="Kelley J" first="Joseph L" last="Kelley">Joseph L. Kelley</name><name sortKey="Olawaiye, Alexander" sort="Olawaiye, Alexander" uniqKey="Olawaiye A" first="Alexander" last="Olawaiye">Alexander Olawaiye</name><name sortKey="Scott, Eirwen" sort="Scott, Eirwen" uniqKey="Scott E" first="Eirwen" last="Scott">Eirwen Scott</name><name sortKey="Smith, Ashlee" sort="Smith, Ashlee" uniqKey="Smith A" first="Ashlee" last="Smith">Ashlee Smith</name><name sortKey="Sukumvanich, Paniti" sort="Sukumvanich, Paniti" uniqKey="Sukumvanich P" first="Paniti" last="Sukumvanich">Paniti Sukumvanich</name></noCountry><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Berger, Jessica" sort="Berger, Jessica" uniqKey="Berger J" first="Jessica" last="Berger">Jessica Berger</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001727 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001727 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25415076
|texte= The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25415076" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |